Fed. Circ. Doubts Vaccine Delivery IP Wrongly Axed By PTAB
A Federal Circuit panel seemed skeptical Friday that the Patent Trial and Appeal Board wrongly sided with Moderna Inc. by finding that an Arbutus Biopharma Corp. patent covering the mRNA delivery...To view the full article, register now.
Already a subscriber? Click here to view full article